BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36964614)

  • 1. Effect of lung ultrasound-guided fluid deresuscitation on duration of ventilation in intensive care unit patients (CONFIDENCE): protocol for a multicentre randomised controlled trial.
    Blok SG; Mousa A; Brouwer MG; de Grooth HJ; Neto AS; Blans MJ; den Boer S; Dormans T; Endeman H; Roeleveld T; Scholten H; van Slobbe-Bijlsma ER; Scholten E; Touw H; van der Ven FSLIM; Wils EJ; van Westerloo DJ; Heunks LMA; Schultz MJ; Paulus F; Tuinman PR
    Trials; 2023 Mar; 24(1):226. PubMed ID: 36964614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized mechanical ventilation guided by ultrasound in patients with acute respiratory distress syndrome (PEGASUS): study protocol for an international randomized clinical trial.
    Sinnige JS; Smit MR; Ghose A; de Grooth HJ; Itenov TS; Ischaki E; Laffey J; Paulus F; Póvoa P; Pierrakos C; Pisani L; Roca O; Schultz MJ; Szuldrzynski K; Tuinman PR; Zimatore C; Bos LDJ;
    Trials; 2024 May; 25(1):308. PubMed ID: 38715118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung Ultrasound Guided Fluid Management Protocol for the Critically Ill Patient: study protocol for a multi-centre randomized controlled trial.
    Rusu DM; Siriopol I; Grigoras I; Blaj M; Ciumanghel AI; Siriopol D; Nistor I; Onofriescu M; Sandu G; Cobzaru B; Scripcariu DV; Diaconu O; Covic AC
    Trials; 2019 Apr; 20(1):236. PubMed ID: 31023358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial.
    Silversides JA; McMullan R; Emerson LM; Bradbury I; Bannard-Smith J; Szakmany T; Trinder J; Rostron AJ; Johnston P; Ferguson AJ; Boyle AJ; Blackwood B; Marshall JC; McAuley DF
    Intensive Care Med; 2022 Feb; 48(2):190-200. PubMed ID: 34913089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PReVENT--protective ventilation in patients without ARDS at start of ventilation: study protocol for a randomized controlled trial.
    Simonis FD; Binnekade JM; Braber A; Gelissen HP; Heidt J; Horn J; Innemee G; de Jonge E; Juffermans NP; Spronk PE; Steuten LM; Tuinman PR; Vriends M; de Vreede G; de Wilde RB; Serpa Neto A; Gama de Abreu M; Pelosi P; Schultz MJ
    Trials; 2015 May; 16():226. PubMed ID: 26003545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Automated Closed-loop ventilation versus convenTional VEntilation on duration and quality of ventilation in critically ill patients (ACTiVE) - study protocol of a randomized clinical trial.
    Botta M; Tsonas AM; Sinnige JS; De Bie AJR; Bindels AJGH; Ball L; Battaglini D; Brunetti I; Buiteman-Kruizinga LA; van der Heiden PLJ; de Jonge E; Mojoli F; Robba C; Schoe A; Paulus F; Pelosi P; Neto AS; Horn J; Schultz MJ;
    Trials; 2022 Apr; 23(1):348. PubMed ID: 35461264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a preventive or curative strategy of fluid removal on the weaning of mechanical ventilation: a study protocol for a multicentre randomised open-label parallel-group trial.
    Dres M; Estellat C; Baudel JL; Beloncle F; Cousty J; Galbois A; Guérin L; Labbe V; Labro G; Lebut J; Mira JP; Prat G; Quenot JP; Dessap A;
    BMJ Open; 2021 Aug; 11(8):e048286. PubMed ID: 34400454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RELAx - REstricted versus Liberal positive end-expiratory pressure in patients without ARDS: protocol for a randomized controlled trial.
    Algera AG; Pisani L; Bergmans DCJ; den Boer S; de Borgie CAJ; Bosch FH; Bruin K; Cherpanath TG; Determann RM; Dondorp AM; Dongelmans DA; Endeman H; Haringman JJ; Horn J; Juffermans NP; van Meenen DM; van der Meer NJ; Merkus MP; Moeniralam HS; Purmer I; Tuinman PR; Slabbekoorn M; Spronk PE; Vlaar APJ; Gama de Abreu M; Pelosi P; Serpa Neto A; Schultz MJ; Paulus F;
    Trials; 2018 May; 19(1):272. PubMed ID: 29739430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.
    Shi Z; Xie H; Wang P; Zhang Q; Wu Y; Chen E; Ng L; Worthington HV; Needleman I; Furness S
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008367. PubMed ID: 23939759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
    Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
    Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restrictive use of Restraints and Delirium Duration in the Intensive Care Unit (R2D2-ICU): protocol for a French multicentre parallel-group open-label randomised controlled trial.
    Sonneville R; Couffignal C; Sigaud F; Godard V; Audibert J; Contou D; Celier A; Djibre M; Schmidt J; Jaquet P; Mekontso Dessap A; Bourel C; Bellot R; Roy C; Lamara F; Essardy F; Timsit JF; Cornic R; Bouadma L;
    BMJ Open; 2024 Apr; 14(4):e083414. PubMed ID: 38631841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunct low-dose ketamine infusion vs standard of care in mechanically ventilated critically ill patients at a Tertiary Saudi Hospital (ATTAINMENT Trial): study protocol for a randomized, prospective, pilot, feasibility trial.
    Bawazeer M; Amer M; Maghrabi K; Alshaikh K; Amin R; Rizwan M; Shaban M; De Vol E; Hijazi M
    Trials; 2020 Mar; 21(1):288. PubMed ID: 32197636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE): study protocol for a randomized controlled trial.
    van der Hoeven SM; Binnekade JM; de Borgie CA; Bosch FH; Endeman H; Horn J; Juffermans NP; van der Meer NJ; Merkus MP; Moeniralam HS; van Silfhout B; Slabbekoorn M; Stilma W; Wijnhoven JW; Schultz MJ; Paulus F
    Trials; 2015 Sep; 16():389. PubMed ID: 26329352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kho ME; Reid J; Molloy AJ; Herridge MS; Seely AJ; Rudkowski JC; Buckingham L; Heels-Ansdell D; Karachi T; Fox-Robichaud A; Ball IM; Burns KEA; Pellizzari JR; Farley C; Berney S; Pastva AM; Rochwerg B; D'Aragon F; Lamontagne F; Duan EH; Tsang JLY; Archambault P; English SW; Muscedere J; Serri K; Tarride JE; Mehta S; Verceles AC; Reeve B; O'Grady H; Kelly L; Strong G; Hurd AH; Thabane L; Cook DJ;
    BMJ Open; 2023 Jun; 13(6):e075685. PubMed ID: 37355270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.